ArticleFrontiers in oncology2024

RAD51 as an immunohistochemistry-based marker of poly(ADP-ribose) polymerase inhibitor resistance in ovarian cancer.

Yoo-Na Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.